Recurrent GBM Brain Tumors with Few Mutations Respond Best to Immunotherapy

Press/Media: Press / Media

PeriodJan 13 2021

Media coverage

1

Media coverage

  • TitleRecurrent GBM Brain Tumors with Few Mutations Respond Best to Immunotherapy
    Media name/outletCorporate.DukeHealth.org
    Country/TerritoryUnited States
    Date1/13/21
    PersonsZhi Wei
View all 1
View less